Figure 7. . Effects of ebselen and ebselen-loaded nanocapsules on normal human dermal fibroblast cells viability.
(A) Cell viability determined after 24 and (B) 48 h. Data were normalized with control (untreated) cell viability (100%) and expressed as the percentage of the mean ± standard deviation (n = 3), *p < 0.01, **p < 0.05.
Eb-NC: Ebselen-loaded core-shell nanocapsule.